Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats
- 20 October 1995
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 59 (2) , 229-239
- https://doi.org/10.1016/0167-0115(95)00099-w
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in ratsCellular and Molecular Neurobiology, 1994
- Simultaneous Monitoring of Intracerebral Release and Behavior: Endogenous Vasopressin Improves Social RecognitionJournal of Neuroendocrinology, 1994
- Neuromodulatory systems and memory storage: Role of the amygdalaBehavioural Brain Research, 1993
- Emotional memory systems in the brainBehavioural Brain Research, 1993
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in ratsPsychoneuroendocrinology, 1993
- Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?Brain Research Reviews, 1990
- ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivityPharmacology Biochemistry and Behavior, 1988
- Activating and ‘anxiogenic’ effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasoneLife Sciences, 1986
- Intraventricular corticotropin-releasing factor enhances behavioral effects of noveltyLife Sciences, 1982